Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.851 | 0.200 | 19 | 7166098 | intron variant | A/G;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.830 | 0.500 | 4 | 2011 | 2020 | ||||||||
|
19 | 7252745 | intron variant | C/T | snv | 9.7E-02 |
|
0.700 | 1.000 | 3 | 2016 | 2018 | ||||||||||
|
19 | 7224420 | intron variant | G/A | snv | 0.38 |
|
0.800 | 1.000 | 3 | 2013 | 2018 | ||||||||||
|
19 | 7257979 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 2 | 2018 | 2019 | |||||||||||
|
0.882 | 0.120 | 19 | 7150407 | intron variant | C/G | snv | 0.75 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2011 | 2014 | |||||||
|
19 | 7252745 | intron variant | C/T | snv | 9.7E-02 |
|
0.700 | 1.000 | 2 | 2016 | 2018 | ||||||||||
|
19 | 7184751 | intron variant | A/G | snv | 0.32 |
|
0.700 | 1.000 | 2 | 2010 | 2014 | ||||||||||
|
19 | 7199967 | intron variant | C/A;G | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
19 | 7199928 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
0.925 | 0.120 | 19 | 7199792 | intron variant | A/G | snv | 0.75 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.925 | 0.120 | 19 | 7199792 | intron variant | A/G | snv | 0.75 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.120 | 19 | 7199792 | intron variant | A/G | snv | 0.75 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
19 | 7211300 | intron variant | C/A;G | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
19 | 7133924 | intron variant | T/C | snv | 0.19 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
19 | 7259335 | intron variant | T/C;G | snv | 0.15 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
19 | 7259335 | intron variant | T/C;G | snv | 0.15 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
0.882 | 0.160 | 19 | 7182952 | intron variant | A/C | snv | 0.25 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | < 0.001 | 1 | 2011 | 2011 | |||||||
|
0.882 | 0.160 | 19 | 7182952 | intron variant | A/C | snv | 0.25 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.160 | 19 | 7182952 | intron variant | A/C | snv | 0.25 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
19 | 7258394 | intron variant | G/C | snv | 0.22 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
19 | 7257979 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
19 | 7257979 | intron variant | C/G;T | snv |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
19 | 7257979 | intron variant | C/G;T | snv |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
19 | 7257979 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
1.000 | 0.120 | 19 | 7184790 | intron variant | C/T | snv | 0.14 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 |